The Hemophilia and Thrombosis Center of Nevada
2020 W. Palomino Lane Suite 110
Las Vegas, Nevada 89106
702-385-2702
since July 3, 2010
Last updated July 3, 2010
webmaster RIS
The Hemophilia and Thrombosis Center of Nevada 2020 W. Palomino Lane Suite 110 Las Vegas, Nevada 89106 702-385-2702
since July 3, 2010 Last updated July 3, 2010 webmaster RIS
|
|
|
Argatroban for Dialysis Catheter Patency Persons on hemodialysis require insertion of heparin into the catheter in order to prevent clotting from occurring. While it is unusual for these patients to develop heparin induced thrombocytopenia, it may occur. For these patients, we published an anectodal report using rifludan to prevent clots. This was done before the newer agent argatroban was available. Rifludan requires normal kidneys to be cleared adequately from the body. However, Argatroban is cleared through the liver. Therefore, it makes sense to use Argatroban instead of Rifludan to see if it is as effective as it may be safer for the patient. This study is closed. Data are being analyzed for future publication. |
|
Send mail to
rshtcn@aol.com with
questions or comments about this web site.
|